Stay updated on Nivolumab Plus Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added Melanoma as a topic on the page. Related topics now include MedlinePlus Genetics.
    Difference
    0.1%
    Check dated 2026-04-02T00:11:07.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Naples, Italy 80131 was added as a study location and Napoli, Italy 80131 was removed, with a revision update to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:09:16.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    No substantive content changes detected; the additions and deletions sections are empty, and the study details appear unchanged.
    Difference
    0.0%
    Check dated 2026-03-18T12:22:18.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Added related topics: Melanoma and MedlinePlus Genetics; updated the page revision from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:58:46.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the funding-status notice, older Revision: v3.4.1 reference, and melanoma-related topic tags.
    Difference
    0.3%
    Check dated 2026-02-11T06:18:06.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A site-wide funding-status notice banner was added to the page, directing users to cc.nih.gov and opm.gov for updates, and the version tag shows Revision: v3.4.1 replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-04T05:14:30.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.